Researchers are exploring how small airway abnormalities in younger smokers could help identify who is at risk of developing ...

The global short-acting beta-agonists market, crucial medications for treating asthma and COPD, is poised for substantial ...

After several days at the frontlines of a wildfire, the firefighters had abruptly developed symptoms ranging from fever to ...

"I look forward to working with Tim Knotnerus and his highly focused team to support the company’s further trajectory." Most recently ... and regeneration in chronic indications such as Fibrostenosing ...

Aug. 22, 2024 — Managing hard-to-treat respiratory illnesses like asthma and pulmonary fibrosis just got easier if a new drug-carrying molecule is as sneaky as its inventors ... COPD and BPD ...

Liquidia LQDA is gearing up to announce its quarterly earnings on Wednesday, 2024-11-13. Here's a quick overview of what ...

United Therapeutics posts impressive Q3 results, driven by Tyvaso, Orenitram, and Unituxin. See why UTHR stock is a buy and ...

As the capital and surrounding areas grapple with hazardous levels of smog, experts are raising alarm over the long-term health consequences, particularly for individuals suffering from chronic ...

Arcutis Biotherapeutics has returned an impressive +200% YTD, following the successful product launch of Zoryve. See why I rate ARQT stock as a Strong Buy.

Device Market. The global oscillating positive expiratory pressure (OPEP) device market is experiencing significant growth, ...

A small asteroid burned up in Earth's atmosphere off the coast of California just hours after being discovered and before impact monitoring systems had registered its trajectory. When you purchase ...

"I look forward to working with Tim Knotnerus and his highly focused team to support the company's further trajectory." Most recently ... and regeneration in chronic indications such as Fibrostenosing ...